Moderna Inc
Moderna Inc

The market is closed (29 nov 03:52 UTC +2)
Current price
Daily range 4.00
174.03 — 182.19

News Moderna Inc

Pfizer's revenue will rise due to higher prices for COVID vaccines

Analysts say Pfizer's plan to increase the price of a COVID-19 vaccine is now four times beyond Wall Street expectations.

24 October
Immune response from Moderna's updated Omicron vaccine persists for 3 months

Moderna Inc's COVID-19 booster vaccine, aimed at the BA.1 Omicron strain, elicits a powerful immune reaction against this subvariant, keeping antibodies at a high level for at least three months, as reported by the company.

21 October
Moderna will make its COVID vaccine available to the poor

On October 17, it was revealed that Moderna, an American biotech company, will provide the world's poorest countries with a new adapted version of the COVID-19 vaccine.

18 October
Moderna and Merck extend partnership

Merck & Co. announced that it will take the opportunity to maintain their partnership with Covid-19 vaccine maker Moderna Inc.

13 October
Moderna refused to reveal its vaccine technology to China

Moderna Inc, an American pharmaceutical company located in Cambridge, Massachusetts, hasn’t approved the transfer of its intellectual property rights for the developed mRNA vaccine against COVID-19 to China.

3 October
Forecasts Moderna Inc
Moderna is ready for a reversal
02 September 2022 72
Moderna’s bearish divergence
05 August 2022 109
It's hard for Moderna to continue its growth
12 July 2022 118

Subscribe to our newsletter and stay up to date with all the news!